ATH 33.3% 0.4¢ alterity therapeutics limited

Good to look at the reference study by Wenning et al, page-7

  1. 2,839 Posts.
    lightbulb Created with Sketch. 995
    Sorry, my reference info is not about 97 patients, but I do not know what would be the right number of patients for this analysis. It is best to wait to get 6-month follow-up for every 10 patients. IMO, the results are promising.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.